Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Veracyte Inc 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 USA

P: 650-243-6300 F: 650-243-6388

Description:

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 1,247,000
Shares Outstanding, K 48,446
Annual Sales, $ 92,010 K
Annual Net Income, $ -23,000 K
Last Quarter Sales, $ 30,140 K
Last Quarter Net Income, $ -2,490 K
60-Month Beta 1.07
% of Insider Shareholders 8.30%
% of Institutional Shareholders 99.64%
Float, K 44,425
% Float 91.70%

Growth:

1-Year Return 131.68%
3-Year Return 269.83%
5-Year Return 150.63%
5-Year Revenue Growth 320.52%
5-Year Earnings Growth 89.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/04/19
Earnings Per Share ttm -0.30
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 72.22%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

VCYT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -10.51
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -10.26
Return-on-Assets (Before Tax) -7.79
Profit Margin % -25.00
Net Margin % N/A
Debt/Equity 0.15
Price/Sales 13.23
Price/Cash Flow N/A
Price/Book 5.43
Book Value/Share 4.63
Interest Coverage -10.73
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar